These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20629949)

  • 1. Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway.
    Leung TH; Yam JW; Chan LK; Ching YP; Ng IO
    Liver Int; 2010 Oct; 30(9):1315-23. PubMed ID: 20629949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human hepatocellular carcinoma cells by Spred2 and correlative studies on its mechanism.
    Ma XN; Liu XY; Yang YF; Xiao FJ; Li QF; Yan J; Zhang QW; Wang LS; Li XY; Wang H
    Biochem Biophys Res Commun; 2011 Jul; 410(4):803-8. PubMed ID: 21703232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
    Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
    J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells.
    Cho SB; Park YL; Song YA; Kim KY; Lee GH; Cho DH; Myung DS; Park KJ; Lee WS; Chung IJ; Choi SK; Kim KK; Joo YE
    Oncol Rep; 2011 Dec; 26(6):1581-6. PubMed ID: 21874262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The inhibitory effect of RNA interference on STAT3 expression in liver cancer cell line SMMC7721].
    Liao WJ; Mei MH; Qin LL; Chen Q; Yuan SG; Liu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):615-7. PubMed ID: 21651859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
    Wang SM; Ooi LL; Hui KM
    Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma.
    Kim TY; Lee JW; Kim HP; Jong HS; Kim TY; Jung M; Bang YJ
    Biochem Biophys Res Commun; 2007 Mar; 355(1):72-7. PubMed ID: 17292327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of RNAi silencing of theWT1 gene on the apoptosis of human hepatocellular carcinoma cell hepG2].
    Huang XQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):771-3. PubMed ID: 20619105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel amplification target, ARHGAP5, promotes cell spreading and migration by negatively regulating RhoA in Huh-7 hepatocellular carcinoma cells.
    Gen Y; Yasui K; Zen K; Nakajima T; Tsuji K; Endo M; Mitsuyoshi H; Minami M; Itoh Y; Tanaka S; Taniwaki M; Arii S; Okanoue T; Yoshikawa T
    Cancer Lett; 2009 Mar; 275(1):27-34. PubMed ID: 18996642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM; Zhang W; Liu NB; Jiang H; Lou KX; Peng T; Ma J; Zhang L; Zhang H; Leng J
    Oncol Rep; 2009 Jan; 21(1):129-36. PubMed ID: 19082453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
    J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
    Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
    Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Shu G; Xie B; Ren F; Liu DC; Zhou J; Li Q; Chen J; Yuan L; Zhou J
    Cell Oncol (Dordr); 2013 Apr; 36(2):121-9. PubMed ID: 23248036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
    Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
    Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
    Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
    Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activity of TAp63 promoter is regulated by c-jun.
    Yao JY; Pao CC; Chen JK
    J Cell Physiol; 2010 Nov; 225(3):898-904. PubMed ID: 20607803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.